We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+11.72%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$249M
AUM Growth
+$11.2M
Cap. Flow
+$1.58M
Cap. Flow %
0.64%
Top 10 Hldgs %
35.47%
Holding
513
New
48
Increased
266
Reduced
45
Closed
120

Top Buys

Rank Stock Value
1
IQ icon
iQIYI
IQ
+$7.05M
2
AMZN icon
Amazon
AMZN
+$3.89M
3
QURE icon
uniQure
QURE
+$2.86M
4
BNTX icon
BioNTech
BNTX
+$2.81M
5
DXCM icon
DexCom
DXCM
+$2.78M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$5.6M
2
PG icon
Procter & Gamble
PG
+$3.27M
3
NVO
Novo Nordisk
NVO
+$3.16M
4
CVS icon
CVS Health
CVS
+$3.1M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.85M

Sector Composition

Rank Sector Weight
1 Technology 35.23%
2 Healthcare 25.2%
3 Consumer Discretionary 20.47%
4 Communication Services 8.05%
5 Financials 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYMR icon
201
Kymera Therapeutics
KYMR
$9.48B
$13.9K 0.01%
557
+72
+15% +$1.92K
ACLX
202
DELISTED
Arcellx
ACLX
$13.8K 0.01%
+445
New +$10.2K
AMPH icon
203
Amphastar Pharmaceuticals
AMPH
$850M
$13.8K 0.01%
491
+32
+7% +$929
REPL icon
204
Replimune Group
REPL
$1.28B
$13.7K 0.01%
505
+43
+9% +$894
TVTX icon
205
Travere Therapeutics
TVTX
$5.86B
$13.7K 0.01%
652
+53
+9% +$1.12K
TWST icon
206
Twist Bioscience
TWST
$7.85B
$13.7K 0.01%
574
+46
+9% +$1.33K
KROS icon
207
Keros Therapeutics
KROS
$222M
$13.4K 0.01%
280
+39
+16% +$1.82K
RNAM
208
DELISTED
Avidity Biosciences
RNAM
$12.3K ﹤0.01%
553
+65
+13% +$969
RETA
209
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$12.3K ﹤0.01%
323
+28
+9% +$964
EQRX
210
DELISTED
EQRx, Inc. Common Stock
EQRX
$12.2K ﹤0.01%
+4,962
New +$19.6K
VERV
211
DELISTED
Verve Therapeutics
VERV
$12.1K ﹤0.01%
626
+65
+12% +$1.72K
MYGN icon
212
Myriad Genetics
MYGN
$309M
$11.9K ﹤0.01%
823
+68
+9% +$1.27K
ZNTL icon
213
Zentalis Pharmaceuticals
ZNTL
$307M
$11.7K ﹤0.01%
579
+45
+8% +$968
CVAC
214
DELISTED
CureVac
CVAC
$11.7K ﹤0.01%
1,933
+177
+10% +$1.31K
BBIO icon
215
BridgeBio Pharma
BBIO
$16.4B
$11.6K ﹤0.01%
1,519
+131
+9% +$1.25K
LGND icon
216
Ligand Pharmaceuticals
LGND
$5.85B
$11.4K ﹤0.01%
171
-84
-33% -$5.46K
DCPH
217
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$11.3K ﹤0.01%
687
+62
+10% +$1.01K
JD icon
218
JD.com
JD
$42.7B
$11.2K ﹤0.01%
200
– –
IMGN
219
DELISTED
Immunogen Inc
IMGN
$11.1K ﹤0.01%
2,242
+175
+8% +$949
ADPT icon
220
Adaptive Biotechnologies
ADPT
$4.02B
$11.1K ﹤0.01%
1,453
+115
+9% +$895
INBX
221
DELISTED
Inhibrx, Inc. Common Stock
INBX
$10.9K ﹤0.01%
442
+77
+21% +$2.26K
ACRS icon
222
Aclaris Therapeutics
ACRS
$860M
$10.7K ﹤0.01%
678
+54
+9% +$869
BLU
223
DELISTED
BELLUS Health Inc.
BLU
$10.5K ﹤0.01%
1,277
+99
+8% +$923
MORF
224
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$10.5K ﹤0.01%
392
+32
+9% +$875
IOVA icon
225
Iovance Biotherapeutics
IOVA
$3.05B
$10.2K ﹤0.01%
1,603
+125
+8% +$976
7 8
9
10 11

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q4 2022 Portfolio in Review

As of Q4 2022, China Universal Asset Management Company held 513 positions worth $249M, up 4.7% from $238M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

China Universal Asset Management Company's Q4 2022 filing shows 48 new, 266 increased, 45 reduced and 120 closed positions. Its largest new stake was iQIYI: 2,418,500 shares worth $12.8M. The largest sale was Tesla, an estimated $5.6M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 36% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • China Universal Asset Management Company's largest Q4 2022 buy was iQIYI: 2,418,500 shares worth $12.8M.
  • China Universal Asset Management Company added most to Amazon in Q4 2022, an estimated $3.89M increase.
  • China Universal Asset Management Company's biggest Q4 2022 reduction was Tesla, cutting an estimated $5.6M.
  • China Universal Asset Management Company fully exited Sprott Physical Gold in Q4 2022, selling an estimated $2.3M.
  • China Universal Asset Management Company's ten largest holdings make up 35% of its $249M portfolio in Q4 2022.
  • China Universal Asset Management Company opened 48 new positions and closed 120 in Q4 2022.
  • China Universal Asset Management Company's portfolio value rose 4.7% quarter-over-quarter to $249M.

Based on China Universal Asset Management Company's 13F filing for Q4 2022, filed 31 Jan 2023.